LIMNW
Liminatus Pharma, Inc. Warrants
stockNASDAQWarrant
EODOct 15, 2026 4:00:00 PM EDT
0.04USD-7.942%(-0.00)213
LIMNW Financials
In Q2 FY 2026 (ended ), Liminatus Pharma, Inc. Warrants (LIMNW) reported net income of −$1.41M, operating cash flow of −$970K, and assets of $3.4M.
Loading financial statements…